Full name :
First name :
Mail :
Zip Code :
City :
Country :
Email :
Phone :
Fax :
Website :
Directory :
| Title : Galantamine hydrobromide: an agent for Alzheimer's disease - Zarotsky_2003_Am.J.Health.Syst.Pharm_60_446 |
| Author(s) : Zarotsky V , Sramek JJ , Cutler NR |
| Ref : Am J Health Syst Pharm , 60 :446 , 2003 |
| Abstract : Zarotsky_2003_Am.J.Health.Syst.Pharm_60_446 |
| ESTHER : Zarotsky_2003_Am.J.Health.Syst.Pharm_60_446 |
| PubMedSearch : Zarotsky_2003_Am.J.Health.Syst.Pharm_60_446 |
| PubMedID: 12635450 |
| Title : Pharmacokinetic-pharmacodynamic modeling of rivastigmine, a cholinesterase inhibitor, in patients with Alzheimer's disease - Gobburu_2001_J.Clin.Pharmacol_41_1082 |
| Author(s) : Gobburu JV , Tammara V , Lesko L , Jhee SS , Sramek JJ , Cutler NR , Yuan R |
| Ref : Journal of Clinical Pharmacology , 41 :1082 , 2001 |
| Abstract : Gobburu_2001_J.Clin.Pharmacol_41_1082 |
| ESTHER : Gobburu_2001_J.Clin.Pharmacol_41_1082 |
| PubMedSearch : Gobburu_2001_J.Clin.Pharmacol_41_1082 |
| PubMedID: 11583476 |
| Title : Review of the next generation of Alzheimer's disease therapeutics: challenges for drug development - Cutler_2001_Prog.Neuropsychopharmacol.Biol.Psychiatry_25_27 |
| Author(s) : Cutler NR , Sramek JJ |
| Ref : Prog Neuropsychopharmacol Biological Psychiatry , 25 :27 , 2001 |
| Abstract : Cutler_2001_Prog.Neuropsychopharmacol.Biol.Psychiatry_25_27 |
| ESTHER : Cutler_2001_Prog.Neuropsychopharmacol.Biol.Psychiatry_25_27 |
| PubMedSearch : Cutler_2001_Prog.Neuropsychopharmacol.Biol.Psychiatry_25_27 |
| PubMedID: 11263756 |
| Title : The status of ongoing trials for mild cognitive impairment - Sramek_2001_Expert.Opin.Investig.Drugs_10_741 |
| Author(s) : Sramek JJ , Veroff AE , Cutler NR |
| Ref : Expert Opin Investig Drugs , 10 :741 , 2001 |
| Abstract : Sramek_2001_Expert.Opin.Investig.Drugs_10_741 |
| ESTHER : Sramek_2001_Expert.Opin.Investig.Drugs_10_741 |
| PubMedSearch : Sramek_2001_Expert.Opin.Investig.Drugs_10_741 |
| PubMedID: 11281823 |
| Title : RBC cholinesterase inhibition: a useful surrogate marker for cholinesterase inhibitor activity in Alzheimer disease therapy? - Sramek_2000_Alzheimer.Dis.Assoc.Disord_14_216 |
| Author(s) : Sramek JJ , Cutler NR |
| Ref : Alzheimer Disease & Associated Disorders , 14 :216 , 2000 |
| Abstract : Sramek_2000_Alzheimer.Dis.Assoc.Disord_14_216 |
| ESTHER : Sramek_2000_Alzheimer.Dis.Assoc.Disord_14_216 |
| PubMedSearch : Sramek_2000_Alzheimer.Dis.Assoc.Disord_14_216 |
| PubMedID: 11186600 |
| Title : Review of the acetylcholinesterase inhibitor galanthamine - Sramek_2000_Expert.Opin.Investig.Drugs_9_2393 |
| Author(s) : Sramek JJ , Frackiewicz EJ , Cutler NR |
| Ref : Expert Opin Investig Drugs , 9 :2393 , 2000 |
| Abstract : Sramek_2000_Expert.Opin.Investig.Drugs_9_2393 |
| ESTHER : Sramek_2000_Expert.Opin.Investig.Drugs_9_2393 |
| PubMedSearch : Sramek_2000_Expert.Opin.Investig.Drugs_9_2393 |
| PubMedID: 11060814 |
| Title : Cholinesterase inhibitors: a therapeutic strategy for Alzheimer disease - Krall_1999_Ann.Pharmacother_33_441 |
| Author(s) : Krall WJ , Sramek JJ , Cutler NR |
| Ref : Annals of Pharmacotherapy , 33 :441 , 1999 |
| Abstract : Krall_1999_Ann.Pharmacother_33_441 |
| ESTHER : Krall_1999_Ann.Pharmacother_33_441 |
| PubMedSearch : Krall_1999_Ann.Pharmacother_33_441 |
| PubMedID: 10332536 |
| Title : NXX-066 in patients with Alzheimer's disease: a bridging study - Sramek_1999_Life.Sci_64_1215 |
| Author(s) : Sramek JJ , Hourani J , Jhee SS , Cutler NR |
| Ref : Life Sciences , 64 :1215 , 1999 |
| Abstract : Sramek_1999_Life.Sci_64_1215 |
| ESTHER : Sramek_1999_Life.Sci_64_1215 |
| PubMedSearch : Sramek_1999_Life.Sci_64_1215 |
| PubMedID: 10210264 |
| Title : Safety and tolerability of metrifonate in patients with Alzheimer's disease: results of a maximum tolerated dose study - Cutler_1998_Life.Sci_62_1433 |
| Author(s) : Cutler NR , Jhee SS , Cyrus P , Bieber F , TanPiengco P , Sramek JJ , Gulanski B |
| Ref : Life Sciences , 62 :1433 , 1998 |
| Abstract : Cutler_1998_Life.Sci_62_1433 |
| ESTHER : Cutler_1998_Life.Sci_62_1433 |
| PubMedSearch : Cutler_1998_Life.Sci_62_1433 |
| PubMedID: 9585171 |
| Title : Dose-dependent CSF acetylcholinesterase inhibition by SDZ ENA 713 in Alzheimer's disease - Cutler_1998_Acta.Neurol.Scand_97_244 |
| Author(s) : Cutler NR , Polinsky RJ , Sramek JJ , Enz A , Jhee SS , Mancione L , Hourani J , Zolnouni P |
| Ref : Acta Neurologica Scandinavica , 97 :244 , 1998 |
| Abstract : Cutler_1998_Acta.Neurol.Scand_97_244 |
| ESTHER : Cutler_1998_Acta.Neurol.Scand_97_244 |
| PubMedSearch : Cutler_1998_Acta.Neurol.Scand_97_244 |
| PubMedID: 9576639 |
| Title : Safety\/tolerability trial of SDZ ENA 713 in patients with probable Alzheimer's disease - Sramek_1996_Life.Sci_58_1201 |
| Author(s) : Sramek JJ , Anand R , Wardle TS , Irwin P , Hartman RD , Cutler NR |
| Ref : Life Sciences , 58 :1201 , 1996 |
| Abstract : Sramek_1996_Life.Sci_58_1201 |
| ESTHER : Sramek_1996_Life.Sci_58_1201 |
| PubMedSearch : Sramek_1996_Life.Sci_58_1201 |
| PubMedID: 8614273 |
| Title : A multiple-dose safety trial of eptastigmine in Alzheimer's disease, with pharmacodynamic observations of red blood cell cholinesterase - Sramek_1995_Life.Sci_56_319 |
| Author(s) : Sramek JJ , Block GA , Reines SA , Sawin SF , Barchowsky A , Cutler NR |
| Ref : Life Sciences , 56 :319 , 1995 |
| Abstract : Sramek_1995_Life.Sci_56_319 |
| ESTHER : Sramek_1995_Life.Sci_56_319 |
| PubMedSearch : Sramek_1995_Life.Sci_56_319 |
| PubMedID: 7837931 |
| Title : Scientific and ethical concerns in clinical trials in Alzheimer's patients: the bridging study [see comments] - Cutler_1995_Eur.J.Clin.Pharmacol_48_421 |
| Author(s) : Cutler NR , Sramek JJ |
| Ref : European Journal of Clinical Pharmacology , 48 :421 , 1995 |
| Abstract : Cutler_1995_Eur.J.Clin.Pharmacol_48_421 |
| ESTHER : Cutler_1995_Eur.J.Clin.Pharmacol_48_421 |
| PubMedSearch : Cutler_1995_Eur.J.Clin.Pharmacol_48_421 |
| PubMedID: 8582458 |
| Title : Acetylcholinesterase inhibition by zifrosilone: pharmacokinetics and pharmacodynamics - Cutler_1995_Clin.Pharmacol.Ther_58_54 |
| Author(s) : Cutler NR , Seifert RD , Schleman MM , Sramek JJ , Szylleyko OJ , Howard DR , Barchowsky A , Wardle TS , Brass EP |
| Ref : Clinical Pharmacology & Therapeutics , 58 :54 , 1995 |
| Abstract : Cutler_1995_Clin.Pharmacol.Ther_58_54 |
| ESTHER : Cutler_1995_Clin.Pharmacol.Ther_58_54 |
| PubMedSearch : Cutler_1995_Clin.Pharmacol.Ther_58_54 |
| PubMedID: 7628183 |
| Title : Alzheimer's patients should be included in phase I clinical trials to evaluate compounds for Alzheimer's disease - Cutler_1992_J.Geriatr.Psychiatry.Neurol_5_192 |
| Author(s) : Cutler NR , Sramek JJ , Murphy MF , Nash RJ |
| Ref : J Geriatr Psychiatry Neurol , 5 :192 , 1992 |
| Abstract : Cutler_1992_J.Geriatr.Psychiatry.Neurol_5_192 |
| ESTHER : Cutler_1992_J.Geriatr.Psychiatry.Neurol_5_192 |
| PubMedSearch : Cutler_1992_J.Geriatr.Psychiatry.Neurol_5_192 |
| PubMedID: 1418362 |
| Title : Implications of the study population in the early evaluation of anticholinesterase inhibitors for Alzheimer's disease - Cutler_1992_Ann.Pharmacother_26_1118 |
| Author(s) : Cutler NR , Sramek JJ , Murphy MF , Nash RJ |
| Ref : Annals of Pharmacotherapy , 26 :1118 , 1992 |
| Abstract : Cutler_1992_Ann.Pharmacother_26_1118 |
| ESTHER : Cutler_1992_Ann.Pharmacother_26_1118 |
| PubMedSearch : Cutler_1992_Ann.Pharmacother_26_1118 |
| PubMedID: 1421679 |